Literature DB >> 15051377

pCLPG: a p53-driven retroviral system.

Bryan E Strauss1, Eugenia Costanzi-Strauss.   

Abstract

We have modified the pCL retroviral system by the insertion of a p53-responsive element, called PG, in the U3 region of the 3'-LTR, either in addition to or in place of the native negative control region/enhancer sequence. We show here that either endogenous or exogenous wild-type p53 may be used to drive expression from the pCLPG system in transduced cells. Upon genotoxic induction of endogenous p53, pCLPG expression surpassed that of the parental, nonmodified virus, specifically when the native promoter was removed and substituted by the p53-responsive element. We propose that the novel pCLPG system will prove to be a valuable tool whether used as a reporter system of p53 function or as an in vitro and in vivo gene transfer vehicle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051377     DOI: 10.1016/j.virol.2003.12.021

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth.

Authors:  Rodrigo Esaki Tamura; Marlous G Lana; Eugenia Costanzi-Strauss; Bryan E Strauss
Journal:  Gene Ther       Date:  2019-03-29       Impact factor: 5.250

2.  Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy.

Authors:  Rodrigo Esaki Tamura; Rafael Bento da Silva Soares; Eugenia Costanzi-Strauss; Bryan E Strauss
Journal:  Cancer Biol Ther       Date:  2016-09-19       Impact factor: 4.742

3.  Activation of endogenous p53 by combined p19Arf gene transfer and nutlin-3 drug treatment modalities in the murine cell lines B16 and C6.

Authors:  Christian A Merkel; Rafael B da Silva Soares; Anna Carolina V de Carvalho; Daniela B Zanatta; Marcio C Bajgelman; Paula Fratini; Eugenia Costanzi-Strauss; Bryan E Strauss
Journal:  BMC Cancer       Date:  2010-06-22       Impact factor: 4.430

4.  Exploration of p53 plus interferon-beta gene transfer for the sensitization of human colorectal cancer cell lines to cell death.

Authors:  Paulo Roberto Del Valle; Samir Andrade Mendonça; Fernanda Antunes; Aline Hunger; Rodrigo E Tamura; Daniela Bertolini Zanatta; Bryan E Strauss
Journal:  Cancer Biol Ther       Date:  2021-04-14       Impact factor: 4.742

Review 5.  Improving adenoviral vectors and strategies for prostate cancer gene therapy.

Authors:  Rodrigo Esaki Tamura; Igor Vieira de Luna; Marlous Gomes Lana; Bryan E Strauss
Journal:  Clinics (Sao Paulo)       Date:  2018-08-20       Impact factor: 2.365

6.  Serial bone marrow transplantation reveals in vivo expression of the pCLPG retroviral vector.

Authors:  Paula Fratini; Bryan E Strauss
Journal:  Virol J       Date:  2010-01-22       Impact factor: 4.099

Review 7.  Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer.

Authors:  Bryan E Strauss; Gissele Rolemberg Oliveira Silva; Igor de Luna Vieira; Otto Luiz Dutra Cerqueira; Paulo Roberto Del Valle; Ruan Felipe Vieira Medrano; Samir Andrade Mendonça
Journal:  Clinics (Sao Paulo)       Date:  2018-09-06       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.